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Abstract 
Introduction 
As part of our ongoing interest in spirochroman-containing natural products,1, 2 our attention was 
drawn to aritasone (1), which has been isolated from Chenopodium ambrosioides.3, 4 It has been 
proposed that aritasone (1) is biosynthesised via a hetero-Diels Alder dimerization of (-)–
pinocarvone (2) (Scheme 1a), which is an abundant component of the essential oil from the plant.  
Cedronellone, the enantiomer of aritasone (1), has been isolated from Cedronella canariensis,5 and 
similarly, this originates from the [4+2] dimerization of (+)-pinocarvone.  During our total synthesis 
of (+)-cymbodiacetal (3),1 we found that the spirochroman intermediate 4 (Scheme 1b), which is 
isomeric with aritasone (1), was formed by the spontaneous hetero-Diels-Alder dimerization of the 
corresponding enone precursor (16, Scheme 2), and we were intrigued by the fact that pinocarvone 
(2) appears to be resistant to [4+2] homodimerization (vide infra).  It is interesting to note that this 
resistance to hetero-Diels-Alder dimerization is also displayed by hypoestoxide (6),6 which is the 
proposed biosynthetic precursor to dihypoestoxide (5) (Scheme 1c), and we felt that attempting to 
synthesise aritasone (1) via the proposed biomimetic [4+2] dimerization route would provide 
valuable insight into the factors controlling this type of hetero-Diels-Alder cycloaddition. 
The only published research on either aritasone (1) or its enantiomer (cedronellone) reports an X-
ray structure of cedronellone, although it was not recognised as a natural product by the authors.7 
This pinocarvone dimer was produced as a side product (10% yield) during a research programme 
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investigating the oxidation products of (−)--pinene, but very few synthetic details were given, as 
the primary focus of the paper was to report the X-ray structure.  The paper indicated that (−)--
pinene was first oxidised with selenium dioxide (no experimental details given), and stated that the 
[4+2] pinocarvone dimer (i.e. cedronellone) “was separated from the steam distilled reaction 
mixture by column chromatography”.  It is unclear at which stage cedronellone was produced, i.e. 
before, during, or after the steam distillation process.  Given the limited experimental information 
provided in this report, we decided to attempt to synthesise pinocarvone via a reliable route, and 
then separately study the hetero-Diels-Alder cyclodimerisation reaction. 
 
Scheme 1 
Thus, (+)--pinene (7) was treated with mCPBA to give the epoxide 8 (87%),8 and subsequent 
rearrangement with Yamamoto’s reagent9 provided allylic alcohol 9 (85%) as the only regioisomer.  
Swern oxidation10 of 9 then cleanly provided (-)-pinocarvone (2) in good yield (80%), which was 
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ready for assessment in the hetero-Diels-Alder reaction.11 For comparison, we also synthesised the 
isomeric carene-derived enone 13 (Scheme 2a),12 and prepared a fresh batch of the limonene-
derived enone 16 (Scheme 2b) that we had used previously in our total synthesis of cymbodiacetal 
3.1 
 
Scheme 2 
With the isomeric enones 2, 13 and 16 tp hand, we then compared their performance in the hetero-
Diels-Alder dimerization reaction.  In our previous work,1 we had found that the limonene-derived 
enone 16 underwent spontaneous room temperature [4+2] homodimerisation to give the 
spirochromans 4endo and 4exo as a 2:1 mixture of diastereoisomers, and we were able to confirm 
this result with our fresh batch of 16.  The reaction could be accelerated by heating 16 to 80 °C, and 
the spirochroman products could be isolated in quantitative yield in a 2:1 ratio after 8 hours 
(Scheme 3). 
 
Scheme 3 
4 
With the successful dimerization of 16 providing the benchmark, we next exposed the isomeric 
carene-derived enone 13 and (–)-pinocarvone 2 to the same reaction conditions (neat, 80 °C).  We 
found that the reactivity of the enone 13 was similar to that of 7, and it underwent dimerisation to 
give a separable mixture of diastereoisomeric spirochromans 17endo and 17exo (5:1) in 
quantitative yield (Scheme 4).  The diastereoisomers were both crystalline solids and X-rayl 
crystallographic analysis confirmed their structures and the stereochemical assignment (Scheme 4). 
 
Scheme 4 
In contrast to the enones 13 and 16, pinocarvone 2 did not produce any of the corresponding 
spirochroman dimerization product (i.e. aritasone 1) upon heating at 80 °C for 8 hours (Scheme 5a).  
Both increases in reaction time (24 hours), and/or reaction temperature (up to 220 °C), failed to 
induce [4+2] cycloaddition, and only decomposition of starting material was observed.  In addition 
to heating neat samples, we also attempted the hetero-Diels Alder reaction of 2 at reflux in a variety 
of solvents (toluene, benzene, dichloromethane, methanol, acetic acid), and with microwave heating 
(water, dichloromethane), but no reaction occurred. We next tried to catalyse the dimerisation of 9 
(ZnCl2, BF3OEt2, pTSA, and proline), but in all cases the dimeric product 1 was not obtained. 
5 
 
Scheme 5 
As pinocarvone 2 proved refractory to hetero-Diels-Alder dimerization, we began to wonder 
whether the initial biosynthetic hypothesis was correct.  As mentioned earlier, the only report of a 
pinocarvone-derived spirochroman dimer (i.e. either aritasone or cedronellone) emerged during a 
study on the allylic oxidation of -pinene 18.7 We wondered whether it was possible for the 
cycloaddition to occur between two pinene-derivatives at different oxidation levels (i.e. 
pinocarvone 2 and -pinene 18), with a post-cycloaddition oxidation providing the fully formed 
spirochroman product 1 (Scheme 5a).  However, no cycloaddition products (20 or 21) were 
observed when pinocarvone 2 was treated with -pinene 18 or pinocarveol 19.  In an attempt to 
achieve any type of [4+2] cycloaddition with pinocarvone 2, we expanded the range of dienophile 
and diene reaction partners (Scheme 5b) to include both electron rich and electron deficient 
versions of both.  In all cases, no cycloaddition was observed with 2 acting either as a heterodiene 
or dienophile, and the starting materials were recovered unchanged.  In the example where 13 was 
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used, only 17endo and 17exo were produced, and no cross hetero-Diels-Alder cycloadducts were 
observed. 
These results clearly show that the three isomeric enones 2, 13 and 16 behave very differently in 
hetero-Diels-Alder reactions, with pinocarvone 2 being resistant to [4+2] cycloaddition under 
standard conditions with a range of reaction partners. As aritasone 1, and its enantiomer 
(cedronellone) clearly exist as natural products, a route must exist for their formation.  Although 
standard conditions did not facilitate the hetero-Diels-Alder dimerization, we postulated that the 
gem-dimethyl-substituted cyclobutane ring present in pinocarvone 2 was leading to steric hindrance 
in the [4+2] dimerization transition state.  As a result, we decided to attempt the cycloaddition 
under ultra-high pressure13-17 to overcome this issue.  Thus, a dichloromethane solution of (–)-
pinocarvone (2) was subjected to 19 Kbar pressure at room temperature for 120 hours, after which 
time a new less polar compound (TLC analysis) had been produced (Scheme 6).  Following 
chromatography, we were pleased to find that aritasone 1 had been formed (58%) as a crystalline 
solid.  The NMR spectroscopic data for our synthetic material matched those previously reported,7 
and the structure was unambiguously confirmed by X-ray crystallography. 
 
Scheme 6 
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Having successfully completed a synthesis of aritasone 1 via the hetero-Diels-Alder dimerization of 
pinocarvone 2, we were struck by the extreme conditions required to achieve this proposed 
biomimetic transformation (19 Kbar pressure).  It seems unlikely that these ultra-high pressures are 
accessible within a plant cell, and it seems sensible to consider alternative possibilities.  Our work 
clearly shows that aritasone 1 (and by analogy cedronellone) are not simple artefacts of isolation 
that result from the spontaneous dimerization of pinocarvone 2, which is much more abundant in 
the plant.  Therefore, it seems likely that there is another process operating for the biosynthesis of 
aritasone 1. 
There has been much interest (and debate) regarding the existence (or not) of Diels-Alderase 
enzymes that are capable of catalysing cyclohexene formation in vivo,18-20 and one possibility could 
be that there is a specific enzyme that catalyses the formation of aritasone 1 by lowering the 
activation barrier to cycloaddition.  This obviously would also require an enzyme to catalyse the 
formation of cedronellone (the enantiomer of aritasone 1), but no evidence currently exists for the 
presence of such enzymes, although hetero-Diels Alderases have been the source of some 
speculation.21  It is also possible that there is an alternative ‘chemical’ explanation for the formation 
of aritasone and cedronellone, and the previously-mentioned formation of cedronellone during the 
oxidation of -pinene might afford a clue as to the nature of this process.  From a purely theoretical 
point of view, the conjugated enone of pinocarvone 2 is required to act as both the hetero-diene and 
also the dienophile in the [4+2] cycloaddition, but it is well established that the ‘best’ 
cycloadditions occur when the HOMO-LUMO energy gap is as low as possible.22 In a dimerisation 
reaction, there is no possibility to affect this energy gap, other than by using catalysts, and we have 
already shown that a variety of common catalysts are ineffective in accelerating the reaction.  An 
alternative approach, however, could involve the oxidation of the enone to form a transient radical 
cation, and this radical cation would have significantly altered HOMO and LUMO energies when 
compared to the neutral, unoxidised starting enone.  The cycloaddition could then occur between a 
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radical cation and the enone,23-25 with the product being reduced to aritasone at a later stage 
(Scheme 7). 
 
Scheme 7 
This radical cation formation could explain the formation of cedronellone during Kohlemainer’s -
pinene oxidation study,7,26 and this oxidative acceleration of [4+2] cycloaddition has been used to 
facilitate the dimerization of cyclohexadiene.27 This methodology has recently been deployed in the 
total synthesis of the natural product kingianin A,28, 29 and could also have significance in the 
biosynthesis of dihypoestoxide 5. 
Experimental 
 (1S,6R)-7,7-dimethyl-4-methylenebicyclo[4.1.0]heptan-3-one 13 
A solution of DMSO (0.380 mL, 5.32 mmol) in CH2Cl2 (3 mL) was added dropwise to a stirred and 
cooled solution of oxalyl chloride (0.230 mL, 2.66 mmol) in CH2Cl2 (5 mL) at −78 C. After 1.5 h a 
solution of allylic alcohol 1212 (200 mg, 1.33 mmol) in CH2Cl2 (5 mL) was added. After a further 
1.5 h, triethylamine (1.66 mL) was added and the mixture was left to stir for 2 h −78 C before the 
cooling bath was removed. Another 15 min of stirring allowed the mixture to warm to 0 C. TLC 
analysis showed full conversion of starting material into product. The reaction was quenched by 
saturated NaHCO3 (30 mL) and diluted with CH2Cl2 (20 mL). The aqueous phase was extracted 
with CH2Cl2 (3 × 20 mL), the combined organic phases were washed with water (2 × 50 mL) and 
dried over MgSO4. The solvent was evaporated under vacuum at 20 C. Purification by column 
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chromatography (pentane/Et2O; 10/1) yielded pure enone 13 (125 mg, 63%) as a colourless oil; Rf 
0.39 (pentane/Et2O; 10/1); []D23 −278.9 (c 0.80 in CHCl3); max/cm-1 (CHCl3) 2948, 2865, 1709, 
1620, 1457; H (400 MHz; CDCl3, 298K) 5.99 (1H, dd, J 2.1 and 0.7, H-8a), 5.18 (1H, br s, H-8b), 
2.85 (1H, dd, J 16.6 and 7.1, H-2a), 2.65 (1H, dd, J 17.5 and 7.3, H-5a),  2.23 (1H, app ddt, J 16.6, 
6.9 and 2.1, H-2b), 2.10 (1H, dd, J 17.5 and 5.7, H-5b), 1.09 (3H, s, CH3), 1.06 (3H, s, CH3), 0.94-
0.84 (2H, m, H-1, H-6); C (100 MHz; CDCl3, 298 K) 201.5 (C), 142.2 (C), 121.2 (CH2), 35.9 
(CH2), 28.3 (CH3), 27.6 (CH2), 20.9 (CH), 20.0 (C), 19.9 (CH), 14.8 (CH3); m/z (ES
+) 173.0948 (M 
+ Na C10H14NaO requires 173.0919). These data were consistent to those previously reported.
30 
 
(1R,2'R,5a'R,6S,6a'S) and (1R,2'S,5a'R,6S,6a'S)-6',6',7,7-tetramethyl-4',5',5a',6',6a',7'-
hexahydro-3'H-spiro[bicyclo[4.1.0]heptane-3,2'-cyclopropa[g]chromen]-4-one 17endo and 
17exo 
The enone (+)-13 (68 mg, 0.46 mmol) was heated in a sealed tube at 80 C for 8 h in an oil bath in 
the absence of solvent. The 1H NMR spectrum of the crude reaction mixture confirmed complete 
consumption of starting material (+)-13, and the residue was purified by column chromatography 
(pentane/Et2O; 15/1) to afford 17endo (55 mg, 81%) and 17exo (10 mg, 16%), both as white solids.  
Analytical data for major dimer 17endo; m.p. 95-96 C; Rf 0.45 (pentane/Et2O; 15/1); []D23 +29.1 
(c 0.91 in CHCl3); max/cm-1 (CHCl3) 2926, 2835, 1720, 1602, 1453; H (400 MHz; CDCl3, 298 K); 
2.82 (1H, dd, J 16.4, 9.2, H-13a), 2.40 (1H, dd, J 15.6, 9.6, H-10a), 2.35-2.22 (3H, m, H-2a, H-5a, 
H-13b), 2.10-1.95 (2H, m, H-2b, H-7a), 1.92 (1H, dd, J 7.3 and 3.5, H-8a), 1.82 (1H, br d, J 16.5, 
H-5b), 1.65-1.55 (1H, m, H-7b), 1.49 (1H, dd, J 15.6, 4.5, H-10b), 1.45-1.37 (1H, m, H-8b), 1.31 
(1H, t, J 8.6, H-12), 1.02 (6H, s, C(CH3)2), 0.85-0.79 (7H, m, H-11, C(CH3)2), 0.77 (1H, t, J  8.81, 
H-3), 0.63 (1H,t, J 8.4, H-4); C (100 MHz; CDCl3, 298 K)  215.9 (C), 143.9 (C), 104.3 (C), 79.0 
(C), 36.4 (CH2), 34.8 (CH2), 28.5 (CH3), 28.5 (CH3), 27.1 (CH2), 25.4 (CH2), 23.3 (CH2), 23.2 
(CH2), 22.9 (CH), 20.0 (C), 19.5 (CH), 18.1 (CH), 17.3 (CH), 16.8 (C), 14.9 (CH3), 13.5 (CH3); m/z 
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(ES+) 301.2162 (M + H C20H29O2 requires 301.2162).  Data for minor dimer 17exo; m.p. 87-90 C; 
Rf 0.21 (pentane/Et2O; 15/1); []D23 +46.5 (c 0.60 in CHCl3); max/cm-1 (CHCl3) 2922, 2963, 2899, 
1715, 1602, 1448; H (400 MHz; CDCl3, 298 K)  2.73 (1H, dd, J 18.2, 8.8, H-13a), 2.50-2.18 (6H, 
m, H-13b, H-2a, H-10a, H-5a, H-7a, H-7b), 2.05 (1H, d, J 18.0, H-2b), 1.98-1.80 (3H, m, H-5b, H-
8a, H-8b), 1.75 (1H, dd, J 14.6, 5.60, H-10b), 1.11 (1H, t, J 8.8, H-12), 1.03 (6H, s, C(CH3)2), 0.95 
(1H, td, J 5.3 and 18.6, H-11), 0.88 (6H, s, C(CH3)2), 0.77 (1H, t, J 8.7, H-3), 0.64 (1H,t, J 8.3, H-
4); C (100 MHz; CDCl3, 298 K)  211.8 (C), 145.1 (C), 101.4 (C), 80.5 (C), 35.5 (CH2), 33.1 
(CH2), 28.9 (CH2), 28.55 (CH3), 28.2 (CH3), 25.5 (CH2), 23.3 (CH2), 23.2 (CH), 22.7 (CH2), 20.3 
(C), 19.4 (CH), 18.7 (CH), 17.9 (CH), 17.1 (C), 15.2 (CH3), 13.3 (CH3); m/z (ES
+) 301.2166 (M + 
H C20H29O2 requires 301.2162). 
 
(1R,3S,5R)-6,6-dimethyl-2-methylenebicyclo[3.1.1]heptan-3-ol 9 
Freshly distilled tetramethylpiperidine (0.55 mL, 3.28 mmol) was diluted with benzene (5 mL) and 
the resulting solution was cooled to 0 C. n-BuLi (1.49 mL, 3.28 mmol, 2.20 M solution in hexanes) 
was then added and the colourless solution turned yellow. After 30 min of stirring, 
diethylaluminiumchloride (3.77 mL, 3.77 mmol, 1 M solution in hexane) was added, the yellow 
colour disappeared and a turbid solution formed. After a further 40 min of stirring at 0 C, the 
epoxide ()-8 (250 mg, 1.64 mmol) was added as a solution in benzene (3 mL). The reaction 
mixture was stirred for 45 min. at 0 C and then for 2 h at room temperature. TLC analysis showed 
full conversion of starting material into product. The reaction was quenched by the slow addition of 
saturated NaHCO3 (15 mL) at 0
 C. The solution was diluted with CHCl3 (30 mL) and the aqueous 
phase was re-extracted with CHCl3 (3 × 20 mL). The combined organic phases were washed with 
brine (30 mL), dried over MgSO4, filteredand evaporated under reduced pressure. Purification by 
column chromatography (pentane/Et2O; 4/1) yielded the pure allylic alcohol ()-9 (213 mg, 85%) 
as a colourless oil; []D26 65.6 (c 0.71 in CHCl3); H (400 MHz; CDCl3, 298K) 5.00 (1H, s, H-8a), 
4.82 (1H, s, H-8b), 4.42 (1H, d, J 7.6 H-3), 2.52 (1H, t, J 5.50, H-1), 2.44-2.35 (1H, m, H-7a), 2.24 
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(1H, dd, J 14.6 and 7.6, H-4a), 2.00 (1H, dd, J 9.8 and 4.6, H-5), 1.85 (1H, dd, J = 14.6 and 4.2, H-
4b), 1.72 (1H, d, J = 9.9, H-7b), 1.48 (1H, br s, OH), 1.28 (3H, s, CH3), 0.50 (3H, s, CH3); C (100 
MHz; CDCl3, 298 K)  156.5 (C), 111.7 (CH2), 67.4 (CH), 50.9 (CH), 40.7 (C), 40.2 (CH), 34.8 
(CH2), 28.3 (CH2), 26.3 (CH3), 22.3 (CH3); HRMS m/z (ES
+) found 153.1275 (M + H C10H18O 
requires 153.1279). 
The same procedure was used for the synthesis of the enantiomer (+)-9 []D23 +60.6 (c 1.96 in 
CHCl3) H’ NMR, 13C NMR, IR and MS data are in accordance with those of ()-9. 
 
(1R,5R)-6,6-dimethyl-2-methylenebicyclo[3.1.1]heptan-3-one (()-pinocarvone 2) 
A solution of DMSO (0.36 mL, 5.12 mmol) in CH2Cl2 (3 mL) was added dropwise to a stirred and 
cooled solution of oxalyl chloride (0.22 mL, 2.56 mmol) in CH2Cl2 (5 mL) at −78 C. After 1.5 h a 
solution of allylic alcohol ()-9 (195 mg, 1.28 mmol) in CH2Cl2 (5 mL) was added, maintaining the 
temperature at −78 C. After a further 1.5 h triethylamine (1.60 mL) was added and the mixture was 
left to stir for 2 h before the cooling bath was removed. Another 15 min stirring allowed the mixture 
to warm to 0 C.  The reaction was quenched by saturated NaHCO3 (30 mL), then diluted with 
CH2Cl2 (20 mL). The aqueous phase was extracted with CH2Cl2 (3 × 20 mL), the combined organic 
phases were washed with water (2 × 50 mL) and dried over MgSO4. After filtration, the solvent was 
evaporated under reduced pressure at 20 C. Purification of the crude product  by column 
chromatography (pentane/Et2O; 10/1) yielded pure enone ()-2 (165 mg, 85%) as a colourless oil; 
[]D27 63.8 (c 0.75 in CHCl3); (lit31 []D 64.7 (neat); H (400 MHz; CDCl3, 298 K) 5.97 (1H, d, J 
1.7, H-8a), 5.01 (1H, d, J 1.7, H-8b), 2.77 (1H, t, J 6.0, H-1), 2.73-2.63 (2H, m, H-4a, H-4b),  2.53 
(1H, dd, J 19.3 and 3.1, H-7a), 2.24-2.17(1H, m, H-7b), 1.4 (3H, s, CH3), 0.88 (1H, t, J 6.9, H-5), 
0.80 (3H, s, CH3); C (100 MHz; CDCl3, 298 K)  200.1 (C), 149.1 (C), 117.5 (CH2), 48.3 (CH), 
42.5 (CH2), 40.8 (C), 38.6 (CH), 26.0 (CH3), 21.6 (CH3); HRMS m/z (ES
+) 301.1421 (2M + H 
C20H29O2 requires 301.2162).  
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The same procedure was used for the synthesis of the enantiomer (+)-2 []D24 +63.4 (c 0.7 in 
CHCl3); (lit []D24 +51.8 (c 0.94 in MeOH); H’ NMR, 13C NMR, IR and MS data are in accordance 
with those of ()-2. 
 
Aritasone (1) 
A solution of pinocarvone (()-2) (100 mg, 0.66 mmol) in dichloromethane (5 mL) was pressurized 
to 19 kBar for 120 h. The 1H NMR spectrum of the crude reaction mixture showed significant 
change in the composition as compared to the starting material. The solvent was evaporated and the 
residue was purified by column chromatography (pentane/Et2O; 25/1) to afford aritasone (1) (20 
mg) as a white solid; mp 101-103 C; (lit3 mp 105-106 °C); []D26 26.1 (c 0.40 in CHCl3); (lit3 
[]D9 118); max/cm-1 (CHCl3) 2926, 2359, 1722, 1689, 1601, 1467, 1372, 1305, 1152; H (400 
MHz; CDCl3, 298 K)  2.67 (2H, app dd, J 4.8, 2.5, H-2a, H-2b), 2.45-2.32 (3H, m, H-7a, H-15a, H-
3), 2.15-2.01 (4H, m, H-10, H-12, H-15b, H-16a), 1.91-1.80 (2H, m, H-4, H-16b), 1.66 (1H, ddd, J 
13.8, 6.4, 3.4, H-7b), 1.38 (3H, s, CH3), 1.29-1.22 (7H, br s, CH3, H-13a, H-13b, H-8a, H-8b), 0.90 
(3H, s, CH3), 0.80 (3H, s, CH3); C (100 MHz; CDCl3, 298 K)  209.5 (C), 142.9 (C), 112.8 (C), 80.8 
(C), 45.2 (CH), 44.3 (CH), 43.7 (CH2), 40.9 (CH), 40.5 (C), 39.4 (CH), 38.3 (C), 33.2 (CH2), 32.7 
(CH2), 27.7 (CH3), 27.3 (CH2), 27.3 (CH3), 26.3 (CH3), 22.5 (CH2), 22.1 (CH2), 20.9 (CH3); HRMS 
m/z (ES+) found 301.2162 (M + H) C20H29O2 requires 301.2162 and 323.1981 (M + Na) 
C20H28O2Na requires 323.1982. These data were consistent to those previously reported.
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Supporting Information Available 
Copies of the 1H and 13C NMR spectra of all new compounds.  This material is available free of 
charge via the Internet at   
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